Ajovy OverviewFremanezumab (INN), marketed under the trade name Ajovy, is a humanized monoclonal antibody directed against calcitonin-related polypeptides (CGRP) alpha and beta. It is used for the preventative treatment of migraine. Fremanezumab was discovered and developed by Rinat Neuroscience, was acquired by Pfizer in 2006, and was then licensed to Teva. History In 2018 Teva stopped development of fremanezumab for the treatment of chronic cluster headache afte...
Read more Ajovy Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Fremanezumab
Recent Ajovy Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 150mg/ml
NDC Database Records for Ajovy: (1 result)Sorted by National Drug Code
- 51759-204 Ajovy 225 mg/1.5ml Subcutaneous Injection by Teva Pharmaceuticals USA, Inc.